71 related articles for article (PubMed ID: 8897309)
1. Thermodynamic parameters of opioid binding in the presence and absence of G-protein coupling.
Fábián G; Benyhe S; Farkas J; Szücs M
J Recept Signal Transduct Res; 1996; 16(3-4):151-68. PubMed ID: 8897309
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic analysis of rat brain opioid mu-receptor-ligand interaction.
Zeman P; Tóth G; Kvetnanský R
Gen Physiol Biophys; 1987 Jun; 6(3):237-48. PubMed ID: 3040520
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
4. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
5. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
Werling LL; Puttfarcken PS; Cox BM
Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
[TBL] [Abstract][Full Text] [Related]
6. Cation and guanine nucleotide effects on ligand binding properties of mu and delta opioid receptors in rat brain membranes.
Benyhe S; Szücs M; Varga E; Simon J; Borsodi A; Wollemann M
Acta Biochim Biophys Hung; 1989; 24(1-2):69-81. PubMed ID: 2558475
[TBL] [Abstract][Full Text] [Related]
7. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
8. 3H-naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding.
Brown GP; Pasternak GW
J Pharmacol Exp Ther; 1998 Jul; 286(1):376-81. PubMed ID: 9655882
[TBL] [Abstract][Full Text] [Related]
9. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta.
Gurdal H; Friedman E; Johnson MD
Mol Pharmacol; 1995 Apr; 47(4):772-8. PubMed ID: 7723738
[TBL] [Abstract][Full Text] [Related]
11. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
12. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents.
Itzhak Y
Mol Pharmacol; 1989 Oct; 36(4):512-7. PubMed ID: 2554109
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
14. [3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues.
Schnittler M; Liebmann C; Schrader U; Schulze HP; Neubert K; Repke H
Biomed Biochim Acta; 1990; 49(4):209-18. PubMed ID: 2169723
[TBL] [Abstract][Full Text] [Related]
15. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
16. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
Werling LL; Brown SR; Puttfarcken P; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
[TBL] [Abstract][Full Text] [Related]
17. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
18. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
Morris BJ; Millan MJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
[TBL] [Abstract][Full Text] [Related]
19. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
20. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites.
Spain JW; Petta DE; Coscia CJ
Mol Pharmacol; 1988 Jul; 34(1):23-8. PubMed ID: 2839762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]